ACADIA Pharmaceuticals, Inc. (ACAD)

22.22 +0.42 (+1.95%) USD  |  NASDAQ  |  Apr 22, 13:23
More

ACADIA Pharmaceuticals Sell Recommendations

Sell Recommendations Chart

View Sell Recommendations for ACAD.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Sell Recommendations Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Sell Recommendations Range, Past 5 Years

View Sell Recommendations Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Sell Recommendations Benchmarks

View Sell Recommendations Benchmarks
Start Trial
Insmed, Inc. Upgrade
Madrigal Pharmaceuticals, Inc. Upgrade
Merck & Co., Inc. Upgrade
Axsome Therapeutics, Inc. Upgrade
Marker Therapeutics, Inc. Upgrade